28 May 2021 3 Min Read
Discovery and Mediclinic scale back plans for vaccine sites amid supply concerns
The companies put brakes on new sites as only 1.3-million Pfizer doses delivered
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In